32d cells Search Results


32d murine myeloid cell line overexpressing bcl-xl  (Quelle GmbH)
90
Quelle GmbH 32d murine myeloid cell line overexpressing bcl-xl
32d Murine Myeloid Cell Line Overexpressing Bcl Xl, supplied by Quelle GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/32d+cells/32d+murine+myeloid+cell+line+overexpressing+bcl+xl/10__1074_slash_jbc__m207272200-60-2-15
Average 90 stars, based on 1 article reviews
32d murine myeloid cell line overexpressing bcl-xl - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier
mouse 32d cells  (China Center for Type Culture Collection)
90
China Center for Type Culture Collection mouse 32d cells
Mouse 32d Cells, supplied by China Center for Type Culture Collection, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/32d+cells/mouse+32d+cells/pm39465372-57-0-7
Average 90 stars, based on 1 article reviews
mouse 32d cells - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier
32d-il-2/15rβ (32dβ) cells  (Altor BioScience)
90
Altor BioScience 32d-il-2/15rβ (32dβ) cells
32d Il 2/15rβ (32dβ) Cells, supplied by Altor BioScience, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/32d+cells/32d+il+2+15r%CE%B2++32d%CE%B2++cells/pmc08889352-169-1-7
Average 90 stars, based on 1 article reviews
32d-il-2/15rβ (32dβ) cells - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier
gene-modified 32d cell lines  (clea japan inc)
90
clea japan inc gene-modified 32d cell lines
iPAI-1 protects chronic myeloid leukemia cells from tyrosine kinase inhibitor treatment. (A) A representative flow cytometric profile for intracellular plasminogen activator inhibitor-1 (iPAI-1) expressions in PAI-1-overexpression (PAI-1 OE), PAI-1-knockdown (PAI-1 KD), or wild-type parental <t>32D</t> p210 cells (PAI-1 WT). (B) Representative flow cytometric profiles and percentage of Annexin V + /PI + population in PAI-1 OE, PAI-1 KD, or PAI-1 WT cells before imatinib (Pre-IM) and after imatinib (Post-IM) treatment in vitro (n=6). (C) Schema for in vivo experiments. (D) Representative flow cytometric profiles and percentages of leukemic cells in the bone marrow (BM) (n=7). Data represent means ± standard deviation. Statistical significance was determined by Mann-Whitney unpaired t -test. P <0.001, by a Kruskal-Wallis test. GFP: green fluorescent protein.
Gene Modified 32d Cell Lines, supplied by clea japan inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/32d+cells/gene+modified+32d+cell+lines/pmc07849585-28-5-15
Average 90 stars, based on 1 article reviews
gene-modified 32d cell lines - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier
32d.3 cells expressing epor and various mutant epors  (Quelle GmbH)
90
Quelle GmbH 32d.3 cells expressing epor and various mutant epors
iPAI-1 protects chronic myeloid leukemia cells from tyrosine kinase inhibitor treatment. (A) A representative flow cytometric profile for intracellular plasminogen activator inhibitor-1 (iPAI-1) expressions in PAI-1-overexpression (PAI-1 OE), PAI-1-knockdown (PAI-1 KD), or wild-type parental <t>32D</t> p210 cells (PAI-1 WT). (B) Representative flow cytometric profiles and percentage of Annexin V + /PI + population in PAI-1 OE, PAI-1 KD, or PAI-1 WT cells before imatinib (Pre-IM) and after imatinib (Post-IM) treatment in vitro (n=6). (C) Schema for in vivo experiments. (D) Representative flow cytometric profiles and percentages of leukemic cells in the bone marrow (BM) (n=7). Data represent means ± standard deviation. Statistical significance was determined by Mann-Whitney unpaired t -test. P <0.001, by a Kruskal-Wallis test. GFP: green fluorescent protein.
32d.3 Cells Expressing Epor And Various Mutant Epors, supplied by Quelle GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/32d+cells/32d+3+cells+expressing+epor+and+various+mutant+epors/pmc00316716-274-13-23
Average 90 stars, based on 1 article reviews
32d.3 cells expressing epor and various mutant epors - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier
32d cells  (Multiplexion GmbH)
90
Multiplexion GmbH 32d cells
iPAI-1 protects chronic myeloid leukemia cells from tyrosine kinase inhibitor treatment. (A) A representative flow cytometric profile for intracellular plasminogen activator inhibitor-1 (iPAI-1) expressions in PAI-1-overexpression (PAI-1 OE), PAI-1-knockdown (PAI-1 KD), or wild-type parental <t>32D</t> p210 cells (PAI-1 WT). (B) Representative flow cytometric profiles and percentage of Annexin V + /PI + population in PAI-1 OE, PAI-1 KD, or PAI-1 WT cells before imatinib (Pre-IM) and after imatinib (Post-IM) treatment in vitro (n=6). (C) Schema for in vivo experiments. (D) Representative flow cytometric profiles and percentages of leukemic cells in the bone marrow (BM) (n=7). Data represent means ± standard deviation. Statistical significance was determined by Mann-Whitney unpaired t -test. P <0.001, by a Kruskal-Wallis test. GFP: green fluorescent protein.
32d Cells, supplied by Multiplexion GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/32d+cells/32d+cells/pmc05293153__MSB___13___904___s014-855-40-50
Average 90 stars, based on 1 article reviews
32d cells - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier
32d-gen cell lines  (Myelo Therapeutics GmbH)
90
Myelo Therapeutics GmbH 32d-gen cell lines
iPAI-1 protects chronic myeloid leukemia cells from tyrosine kinase inhibitor treatment. (A) A representative flow cytometric profile for intracellular plasminogen activator inhibitor-1 (iPAI-1) expressions in PAI-1-overexpression (PAI-1 OE), PAI-1-knockdown (PAI-1 KD), or wild-type parental <t>32D</t> p210 cells (PAI-1 WT). (B) Representative flow cytometric profiles and percentage of Annexin V + /PI + population in PAI-1 OE, PAI-1 KD, or PAI-1 WT cells before imatinib (Pre-IM) and after imatinib (Post-IM) treatment in vitro (n=6). (C) Schema for in vivo experiments. (D) Representative flow cytometric profiles and percentages of leukemic cells in the bone marrow (BM) (n=7). Data represent means ± standard deviation. Statistical significance was determined by Mann-Whitney unpaired t -test. P <0.001, by a Kruskal-Wallis test. GFP: green fluorescent protein.
32d Gen Cell Lines, supplied by Myelo Therapeutics GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/32d+cells/32d+gen+cell+lines/pm09519783-115-75-25
Average 90 stars, based on 1 article reviews
32d-gen cell lines - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier
32d clone no. 13 cells  (Johns Hopkins HealthCare)
90
Johns Hopkins HealthCare 32d clone no. 13 cells
iPAI-1 protects chronic myeloid leukemia cells from tyrosine kinase inhibitor treatment. (A) A representative flow cytometric profile for intracellular plasminogen activator inhibitor-1 (iPAI-1) expressions in PAI-1-overexpression (PAI-1 OE), PAI-1-knockdown (PAI-1 KD), or wild-type parental <t>32D</t> p210 cells (PAI-1 WT). (B) Representative flow cytometric profiles and percentage of Annexin V + /PI + population in PAI-1 OE, PAI-1 KD, or PAI-1 WT cells before imatinib (Pre-IM) and after imatinib (Post-IM) treatment in vitro (n=6). (C) Schema for in vivo experiments. (D) Representative flow cytometric profiles and percentages of leukemic cells in the bone marrow (BM) (n=7). Data represent means ± standard deviation. Statistical significance was determined by Mann-Whitney unpaired t -test. P <0.001, by a Kruskal-Wallis test. GFP: green fluorescent protein.
32d Clone No. 13 Cells, supplied by Johns Hopkins HealthCare, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/32d+cells/32d+clone+no++13+cells/pm09519783-28-6-15
Average 90 stars, based on 1 article reviews
32d clone no. 13 cells - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier
32d clone 23 cells  (Genesis Research and Development)
90
Genesis Research and Development 32d clone 23 cells
iPAI-1 protects chronic myeloid leukemia cells from tyrosine kinase inhibitor treatment. (A) A representative flow cytometric profile for intracellular plasminogen activator inhibitor-1 (iPAI-1) expressions in PAI-1-overexpression (PAI-1 OE), PAI-1-knockdown (PAI-1 KD), or wild-type parental <t>32D</t> p210 cells (PAI-1 WT). (B) Representative flow cytometric profiles and percentage of Annexin V + /PI + population in PAI-1 OE, PAI-1 KD, or PAI-1 WT cells before imatinib (Pre-IM) and after imatinib (Post-IM) treatment in vitro (n=6). (C) Schema for in vivo experiments. (D) Representative flow cytometric profiles and percentages of leukemic cells in the bone marrow (BM) (n=7). Data represent means ± standard deviation. Statistical significance was determined by Mann-Whitney unpaired t -test. P <0.001, by a Kruskal-Wallis test. GFP: green fluorescent protein.
32d Clone 23 Cells, supplied by Genesis Research and Development, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/32d+cells/32d+clone+23+cells/pm09211864-54-6-26
Average 90 stars, based on 1 article reviews
32d clone 23 cells - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier
cell line 32d-raf  (Quelle GmbH)
90
Quelle GmbH cell line 32d-raf
iPAI-1 protects chronic myeloid leukemia cells from tyrosine kinase inhibitor treatment. (A) A representative flow cytometric profile for intracellular plasminogen activator inhibitor-1 (iPAI-1) expressions in PAI-1-overexpression (PAI-1 OE), PAI-1-knockdown (PAI-1 KD), or wild-type parental <t>32D</t> p210 cells (PAI-1 WT). (B) Representative flow cytometric profiles and percentage of Annexin V + /PI + population in PAI-1 OE, PAI-1 KD, or PAI-1 WT cells before imatinib (Pre-IM) and after imatinib (Post-IM) treatment in vitro (n=6). (C) Schema for in vivo experiments. (D) Representative flow cytometric profiles and percentages of leukemic cells in the bone marrow (BM) (n=7). Data represent means ± standard deviation. Statistical significance was determined by Mann-Whitney unpaired t -test. P <0.001, by a Kruskal-Wallis test. GFP: green fluorescent protein.
Cell Line 32d Raf, supplied by Quelle GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/32d+cells/cell+line+32d+raf/pmc00316716-293-23-18
Average 90 stars, based on 1 article reviews
cell line 32d-raf - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier
32d cells  (BioResource International Inc)
90
BioResource International Inc 32d cells
iPAI-1 protects chronic myeloid leukemia cells from tyrosine kinase inhibitor treatment. (A) A representative flow cytometric profile for intracellular plasminogen activator inhibitor-1 (iPAI-1) expressions in PAI-1-overexpression (PAI-1 OE), PAI-1-knockdown (PAI-1 KD), or wild-type parental <t>32D</t> p210 cells (PAI-1 WT). (B) Representative flow cytometric profiles and percentage of Annexin V + /PI + population in PAI-1 OE, PAI-1 KD, or PAI-1 WT cells before imatinib (Pre-IM) and after imatinib (Post-IM) treatment in vitro (n=6). (C) Schema for in vivo experiments. (D) Representative flow cytometric profiles and percentages of leukemic cells in the bone marrow (BM) (n=7). Data represent means ± standard deviation. Statistical significance was determined by Mann-Whitney unpaired t -test. P <0.001, by a Kruskal-Wallis test. GFP: green fluorescent protein.
32d Cells, supplied by BioResource International Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/32d+cells/32d+cells/us09987278-332-1-7
Average 90 stars, based on 1 article reviews
32d cells - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier
32d cell line  (China Center for Type Culture Collection)
90
China Center for Type Culture Collection 32d cell line
iPAI-1 protects chronic myeloid leukemia cells from tyrosine kinase inhibitor treatment. (A) A representative flow cytometric profile for intracellular plasminogen activator inhibitor-1 (iPAI-1) expressions in PAI-1-overexpression (PAI-1 OE), PAI-1-knockdown (PAI-1 KD), or wild-type parental <t>32D</t> p210 cells (PAI-1 WT). (B) Representative flow cytometric profiles and percentage of Annexin V + /PI + population in PAI-1 OE, PAI-1 KD, or PAI-1 WT cells before imatinib (Pre-IM) and after imatinib (Post-IM) treatment in vitro (n=6). (C) Schema for in vivo experiments. (D) Representative flow cytometric profiles and percentages of leukemic cells in the bone marrow (BM) (n=7). Data represent means ± standard deviation. Statistical significance was determined by Mann-Whitney unpaired t -test. P <0.001, by a Kruskal-Wallis test. GFP: green fluorescent protein.
32d Cell Line, supplied by China Center for Type Culture Collection, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/32d+cells/32d+cell+line/pm22513084-23-1-21
Average 90 stars, based on 1 article reviews
32d cell line - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

Image Search Results


iPAI-1 protects chronic myeloid leukemia cells from tyrosine kinase inhibitor treatment. (A) A representative flow cytometric profile for intracellular plasminogen activator inhibitor-1 (iPAI-1) expressions in PAI-1-overexpression (PAI-1 OE), PAI-1-knockdown (PAI-1 KD), or wild-type parental 32D p210 cells (PAI-1 WT). (B) Representative flow cytometric profiles and percentage of Annexin V + /PI + population in PAI-1 OE, PAI-1 KD, or PAI-1 WT cells before imatinib (Pre-IM) and after imatinib (Post-IM) treatment in vitro (n=6). (C) Schema for in vivo experiments. (D) Representative flow cytometric profiles and percentages of leukemic cells in the bone marrow (BM) (n=7). Data represent means ± standard deviation. Statistical significance was determined by Mann-Whitney unpaired t -test. P <0.001, by a Kruskal-Wallis test. GFP: green fluorescent protein.

Journal: Haematologica

Article Title: Targeting of plasminogen activator inhibitor-1 activity promotes elimination of chronic myeloid leukemia stem cells

doi: 10.3324/haematol.2019.230227

Figure Lengend Snippet: iPAI-1 protects chronic myeloid leukemia cells from tyrosine kinase inhibitor treatment. (A) A representative flow cytometric profile for intracellular plasminogen activator inhibitor-1 (iPAI-1) expressions in PAI-1-overexpression (PAI-1 OE), PAI-1-knockdown (PAI-1 KD), or wild-type parental 32D p210 cells (PAI-1 WT). (B) Representative flow cytometric profiles and percentage of Annexin V + /PI + population in PAI-1 OE, PAI-1 KD, or PAI-1 WT cells before imatinib (Pre-IM) and after imatinib (Post-IM) treatment in vitro (n=6). (C) Schema for in vivo experiments. (D) Representative flow cytometric profiles and percentages of leukemic cells in the bone marrow (BM) (n=7). Data represent means ± standard deviation. Statistical significance was determined by Mann-Whitney unpaired t -test. P <0.001, by a Kruskal-Wallis test. GFP: green fluorescent protein.

Article Snippet: Another set of experiments, gene-modified 32D cell lines were also transplanted into non-irradiated C3H/HeNCrl mice (CLEA Japan).

Techniques: Over Expression, In Vitro, In Vivo, Standard Deviation, MANN-WHITNEY